Member Info for Aether

Manifesto what does all that mean in layman's language? Thanks.

He is showing signs of mental illness and is being malicious. Block him for you health.

Polygon will move swiftly to recoup their investment. I suspect they won't wait around for the results of another clinical trial. The data from ACTIV-2 P2 and SPRINTER 3 are critical for this to be resolved in the short term. If there are gems in the data, how much would a Big Pharma pay for it?

Thank you for your measured post, TLWilliams.

"Due to these changes in the pandemic, a new clinical trial design is needed to evaluate the efficacy of SNG001 against COVID-19. As a result, lead investigators from ACTIV-2 and Synairgen are in ongoing discussions to try to identify an appropriate clinical trial to continue the evaluation of SNG001."

THIS is the reason why the trial was halted.

Note the words, "... lead investigator from ACTI-2 and Synairgen are in ongoing discussions to try to identify an appropriate clinical trial to continue the evaluation of SNG001."

So, if POLYGON wanted to recoup and exit quickly, all they have to do is wait for good results from the Deep Dive and negotiate and force a sale to a Big Pharma?

So, if the data from ACTIV-2 and SPRINTER are good. This company could be sold to a Big Pharma without waiting for further Clinical Trials?

The drug works.

The safety profile is immense.

It is variant agnostic.

It reduces deaths by 40%.

It has the potential for many applications a Big Pharma could use.

Roughly how much?

How much would a big pharma pay for the IP if the data from ACTIV-2 and/or SPRINTER is good?

So, it is potentially good news for CEY shareholders?

What will be the potential impact on CEY?

If POLYGON take control at 30 per cent and sell to a Big Pharma, how much would this be worth?

50p+?

A TO on good data from SPRINTER and ACTIV-2 P3 is more likely.

Long COVID data would be very useful.

About 100 to 150p.

So, are they continuing to make a mistake?

POLYGON will want to sell and realize a profit swiftly.

They are a ruthless hedgefund they are no in the business of being a long term holders.

They will either want to move for an EUA or sell it to Big Pharma.

I suspect they will apply pressure to SNG to maximise their profits whatever their decision.

They kept buying after the Monday RNS after discussions with SNG and now own ~25%.

Why?

To average down and sell at a lower price? No. They own £80M+

They suspect there is good data to be revealed? Yes.

What do they want?

To at least break even and make a profit.

Will they take their time and hold for new trials or sell to Big Pharma?

POLYGON are at about 25%.

They are a ruthless hedgefund and are STILL BUYING more shares.

They want to make a profit. They will not allow anything to stand in their way.

How do you green bin someone?

POLYGON are the difference.

They are a ruthless hedgefund and have invested £80m.

They will want to make money relatively quickly.